Clinical Trial Update: Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic data for LCP-Tacro were evaluated in stable liver transplant patients. The study was sponsored by Veloxis Pharmaceuticals and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure
• Liver Transplantation

Drugs mentioned

• LCP-Tacro (tacrolimus)

Snippet

Sponsor: Veloxis Pharmaceuticals | Conditions: Liver Failure | Phase 2 | Status: COMPLETED | Results posted: 2015-08-28